Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Since the discovery of the retinoblastoma susceptibility gene (RB1) decades ago, RB1 has been regarded as a prototype tumor suppressor gene providing a paradigm for tumor genetic research. Constant research has updated the understanding of RB1-related pathways and their impact on tumor and nontumor diseases. Mutation of RB1 gene has been observed in multiple types of malignant tumors including prostate cancer, lung cancer, breast cancer, and almost every familial and sporadic case of retinoblastoma. Even if well-known and long-investigated, the application potential of RB1 mutation has not been fully tapped. In this review, we focus on the mechanism underlying RB1 mutation during oncogenesis. Therapeutically, we have further discussed potential clinical strategies by targeting RB1-mutated cancers. The unsolved problems and prospects of RB1 mutation are also discussed. Copyright © 2022 Elsevier B.V. All rights reserved.

Citation

Yiran Yao, Xiang Gu, Xiaofang Xu, Shengfang Ge, Renbing Jia. Novel insights into RB1 mutation. Cancer letters. 2022 Oct 28;547:215870

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35964818

View Full Text